ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 147 filers reported holding ROCKET PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,233,027 | +13.7% | 60,177 | +10.3% | 0.22% | +15.4% |
| Q2 2023 | $1,084,286 | +16.7% | 54,569 | +0.6% | 0.19% | +12.6% |
| Q1 2023 | $928,994 | -12.6% | 54,232 | -0.2% | 0.17% | -12.6% |
| Q4 2022 | $1,063,121 | +17.0% | 54,324 | -4.6% | 0.19% | +5.5% |
| Q3 2022 | $909,000 | +9.3% | 56,951 | -5.8% | 0.18% | +13.8% |
| Q2 2022 | $832,000 | +20.2% | 60,475 | +38.5% | 0.16% | +43.2% |
| Q1 2022 | $692,000 | -13.1% | 43,655 | +19.8% | 0.11% | -5.1% |
| Q4 2021 | $796,000 | -29.5% | 36,449 | -3.5% | 0.12% | -32.4% |
| Q3 2021 | $1,129,000 | -31.8% | 37,782 | +1.1% | 0.17% | -28.8% |
| Q2 2021 | $1,655,000 | +28.4% | 37,360 | +28.6% | 0.24% | +20.3% |
| Q1 2021 | $1,289,000 | -31.8% | 29,061 | -15.7% | 0.20% | -35.3% |
| Q4 2020 | $1,890,000 | +69.5% | 34,464 | -29.4% | 0.31% | +52.2% |
| Q3 2020 | $1,115,000 | +9.6% | 48,795 | +0.4% | 0.20% | +6.8% |
| Q2 2020 | $1,017,000 | +29.1% | 48,577 | -14.0% | 0.19% | +10.3% |
| Q1 2020 | $788,000 | +15.2% | 56,458 | +87.8% | 0.17% | +47.5% |
| Q4 2019 | $684,000 | – | 30,058 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 16,812,491 | $234,534,000 | 10.10% |
| TANG CAPITAL MANAGEMENT LLC | 2,965,485 | $41,369,000 | 5.81% |
| Ghost Tree Capital, LLC | 650,000 | $9,068,000 | 2.40% |
| Boxer Capital, LLC | 1,466,051 | $20,451,000 | 1.39% |
| Vivo Capital, LLC | 860,648 | $12,006,000 | 1.09% |
| Samsara BioCapital, LLC | 128,197 | $1,788,000 | 1.03% |
| Cormorant Asset Management, LP | 1,568,550 | $21,881,000 | 1.02% |
| Perceptive Advisors | 2,189,010 | $30,537,000 | 0.80% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,677,367 | $23,399,000 | 0.74% |
| Eventide Asset Management | 1,415,000 | $19,739,000 | 0.64% |